GIVLAARI® (givosiran) Treats acute hepatic porphyria in adults with an approved RNAi medicine that reduces production of toxic intermediates associated with porphyria attacks.
Visit productCosigns Received
Be the first Cosign
Put your name behind GIVLAARI® (givosiran).
Add it to your Products I use list and share why you use it.